Fortrea Holdings Inc
NASDAQ:FTRE
Relative Value
The Relative Value of one FTRE stock under the Base Case scenario is 50.53 USD. Compared to the current market price of 26.91 USD, Fortrea Holdings Inc is Undervalued by 47%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
FTRE Competitors Multiples
Fortrea Holdings Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
F
|
Fortrea Holdings Inc
NASDAQ:FTRE
|
2.4B USD | 0.8 | -702.8 | 20.9 | 44 | |
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
226.7B USD | 5.3 | 37.6 | 23.4 | 34.2 | ||
US |
Danaher Corp
NYSE:DHR
|
198B USD | 4.5 | 24.5 | 17.8 | 21.9 | ||
US |
Agilent Technologies Inc
NYSE:A
|
45.3B USD | 6.7 | 36.7 | 29.2 | 35.2 | ||
CH |
Lonza Group AG
SIX:LONN
|
38.2B CHF | 5.7 | 58.4 | 20 | 29.4 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
41.8B USD | 2.8 | 30.8 | 16.7 | 25.9 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
56.2T KRW | 15.2 | 65.6 | 34.6 | 49.8 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
32.4B USD | 8.6 | 41.6 | 28.4 | 31.6 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
26.4B USD | 3.2 | 38.7 | 17.4 | 26.7 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
25.1B USD | 8.6 | 44.1 | 30.5 | 37.1 | ||
US |
Waters Corp
NYSE:WAT
|
21B USD | 7.2 | 34.8 | 23.3 | 28.8 |